BACC: Protocol for Rapid Diagnosis of Myocardial Infraction

The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe.

To carry out the BACC study (Biomarkers in Acute Cardiovascular Care) the effects of the troponin assay at 1 hour were compared to its effects after the 3 hours recommended by the ESC guidelines in 1.045 patients presenting with acute chest pain (mean age 65, 64.9% male). In addition, they analyzed a cut off value of 6 ng/L, far lower than the recommended 27 ng/L 99th percentile value for the ultrasensitive troponin assay (Elecsys; Roche Diagnostics) and the high sensitivity troponin I assay (STAT hs Tn I; Abbott Diagnostics).

The use of ultrasensitive cTn I with a ≤ 6 ng/L cutoff ruled out STEMI in 402 patients after an hour, and no differences were observed when compared to discharge at 3 hours. Moreover, compared to the 6 ng/L, the 27 ng/L cutoff resulted in a lower negative predictive value (NPV), regardless testing time (P < .005 for both) and also resulted in lower sensitivity.

An algorithm to rule out NSTEMI should include the ultrasensitive cTn I > 6 ng/L after one hour with a 12 ng/L delta compared to admission values (positive predictive value PPV 87.1%; specificity 98.0%).

These algorithms were verified against 4.009 patients from the European cohort (NPV 99.2% rule out, PPV 80.4% rule in) that also used a 1 hour algorithm, and against the Australian cohort (NPV 99.7% rule out; VPP 81.5% rule in).

During a 183 day follow up, only 3 patients died (0.79%) in the rule out < 6 ng/L group. However, 12 had died (1.73%) using the 27 ng/L cut off value (P < .05).

Westermann D.

More articles by this author

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Left Main Coronary Artery Disease: Intravascular Imaging-Guided PCI vs. Coronary Artery Bypass Grafting

Multiple randomized clinical trials have demonstrated superior outcomes with coronary artery bypass grafting (CABG) vs. percutaneous coronary intervention (PCI) in patients with left main...

AHA 2025 | OCEAN Study: Anticoagulation vs. Antiplatelet Therapy After Successful Atrial Fibrillation Ablation

After a successful atrial fibrillation (AF) ablation, the need to maintain long-term anticoagulation (AC) remains uncertain, especially considering the very low residual embolic risk...

AHA 2025 | VESALIUS-CV: Evolocumab in High-Cardiovascular-Risk Patients Without Prior MI or Stroke

LDL cholesterol is a well-established factor for cardiovascular disease. Therapy with PCSK9 inhibitors, including evolocumab, has been shown to reduce the risk of cardiovascular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....